Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition. Bast, T., Pezze, M., & McGarrity, S. Br. J. Pharmacol., 174(19):3211--3225, October, 2017. 00000
Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition [link]Paper  doi  abstract   bibtex   
We review recent evidence concerning the significance of inhibitory GABA transmission and of neural disinhibition, that is, deficient GABA transmission, within the prefrontal cortex and the hippocampus, for clinically relevant cognitive functions. Both regions support important cognitive functions, including attention and memory, and their dysfunction has been implicated in cognitive deficits characterizing neuropsychiatric disorders. GABAergic inhibition shapes cortico-hippocampal neural activity, and, recently, prefrontal and hippocampal neural disinhibition has emerged as a pathophysiological feature of major neuropsychiatric disorders, especially schizophrenia and age-related cognitive decline. Regional neural disinhibition, disrupting spatio-temporal control of neural activity and causing aberrant drive of projections, may disrupt processing within the disinhibited region and efferent regions. Recent studies in rats showed that prefrontal and hippocampal neural disinhibition (by local GABA antagonist microinfusion) dysregulates burst firing, which has been associated with important aspects of neural information processing. Using translational tests of clinically relevant cognitive functions, these studies showed that prefrontal and hippocampal neural disinhibition disrupts regional cognitive functions (including prefrontal attention and hippocampal memory function). Moreover, hippocampal neural disinhibition disrupted attentional performance, which does not require the hippocampus but requires prefrontal-striatal circuits modulated by the hippocampus. However, some prefrontal and hippocampal functions (including inhibitory response control) are spared by regional disinhibition. We consider conceptual implications of these findings, regarding the distinct relationships of distinct cognitive functions to prefrontal and hippocampal GABA tone and neural activity. Moreover, the findings support the proposition that prefrontal and hippocampal neural disinhibition contributes to clinically relevant cognitive deficits, and we consider pharmacological strategies for ameliorating cognitive deficits by rebalancing disinhibition-induced aberrant neural activity. Linked Articles This article is part of a themed section on Pharmacology of Cognition: a Panacea for Neuropsychiatric Disease? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.19/issuetoc.
@article{bast_cognitive_2017,
	title = {Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition},
	volume = {174},
	issn = {0007-1188},
	url = {http://dx.doi.org/10.1111/bph.13850},
	doi = {10.1111/bph.13850},
	abstract = {We review recent evidence concerning the significance of inhibitory GABA
transmission and of neural disinhibition, that is, deficient GABA
transmission, within the prefrontal cortex and the hippocampus, for
clinically relevant cognitive functions. Both regions support important
cognitive functions, including attention and memory, and their dysfunction
has been implicated in cognitive deficits characterizing neuropsychiatric
disorders. GABAergic inhibition shapes cortico-hippocampal neural
activity, and, recently, prefrontal and hippocampal neural disinhibition
has emerged as a pathophysiological feature of major neuropsychiatric
disorders, especially schizophrenia and age-related cognitive decline.
Regional neural disinhibition, disrupting spatio-temporal control of
neural activity and causing aberrant drive of projections, may disrupt
processing within the disinhibited region and efferent regions. Recent
studies in rats showed that prefrontal and hippocampal neural
disinhibition (by local GABA antagonist microinfusion) dysregulates burst
firing, which has been associated with important aspects of neural
information processing. Using translational tests of clinically relevant
cognitive functions, these studies showed that prefrontal and hippocampal
neural disinhibition disrupts regional cognitive functions (including
prefrontal attention and hippocampal memory function). Moreover,
hippocampal neural disinhibition disrupted attentional performance, which
does not require the hippocampus but requires prefrontal-striatal circuits
modulated by the hippocampus. However, some prefrontal and hippocampal
functions (including inhibitory response control) are spared by regional
disinhibition. We consider conceptual implications of these findings,
regarding the distinct relationships of distinct cognitive functions to
prefrontal and hippocampal GABA tone and neural activity. Moreover, the
findings support the proposition that prefrontal and hippocampal neural
disinhibition contributes to clinically relevant cognitive deficits, and
we consider pharmacological strategies for ameliorating cognitive deficits
by rebalancing disinhibition-induced aberrant neural activity. Linked
Articles This article is part of a themed section on Pharmacology of
Cognition: a Panacea for Neuropsychiatric Disease? To view the other
articles in this section visit
http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.19/issuetoc.},
	number = {19},
	journal = {Br. J. Pharmacol.},
	author = {Bast, Tobias and Pezze, Marie and McGarrity, Stephanie},
	month = oct,
	year = {2017},
	note = {00000},
	keywords = {Sep 20 import, duplicate},
	pages = {3211--3225}
}

Downloads: 0